Clinical Trial Update: [68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating [68Ga]Ga-ABY-025 PET for quantifying HER2 status in solid tumors, including esophageal and gastric neoplasms, with co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Neoplasms
• Gastric Cancer
• Gastric Neoplasms Malignant

Drugs mentioned

• [68Ga]Ga-ABY-025 (ABY-025)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Esophageal Neoplasms, Gastric Neoplasms Malignant | Phase 2 | Status: UNKNOWN